EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access

Incidence of Statin Initiation Among People With and Without HIV in the United States: A Prospective Observational Study

Tiffany L Breger iD, Daniel J Westreich iD, Andrew Edmonds iD, Jessie K Edwards iD, Stephen R Cole, Catalina Ramirez iD, Alicia E Diggs, Igho Ofotokun iD, Seble G Kassaye, Todd T Brown, Deborah Konkle-Parker iD, Frank J Palella und 11 weitere

Clinical Infectious Diseases · 2025

DOI: 10.1093/cid/ciaf207 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Tiffany L Breger und 22 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: HIV Infections, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Eunice Kennedy Shriver National Institute of Child Health & Human Development, DC CTSA, National Institutes of Health, Office of AIDS Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To reduce atherosclerotic cardiovascular disease (ASCVD) among US people with human immunodeficiency virus (HIV, PWH), it is critical to assess shortfalls in statin initiation. We aimed to describe patterns in clinically indicated statin initiation among demographically similar people with or at increased vulnerability to HIV.

Methods

Using data from the Multicenter AIDS Cohort Study and Women's Interagency HIV Study, we followed 842 men and 852 women with an indication for statin use based on 2013 American College of Cardiology/American Heart Association guidelines for statin initiation between January 2014 and March 2020. We estimated 2-year incidence of statin initiation stratified by demographic, clinical, and behavioral characteristics and compared estimates using incidence differences.

Results

Within 2 years of statin indication, 20% of participants reported statin use. Initiation of statin therapy did not differ significantly by HIV status. However, initiation was lower among Black versus non-Black persons, especially among men (14.0% versus 22.3%; difference, −8.3%; 95% confidence interval, −13.8% to −2.8%). Compared with initiation among persons indicated based only on ≥7.5% 10-year predicted ASCVD risk (incidence: men, 14.2%; women, 15.2%), initiation was higher among those with existing ASCVD (incidence: men, 32.9%; women, 22.0%) or diabetes (incidence: men, 26.4%; women, 24.5%). Initiation was lower among current versus noncurrent smokers and higher among those with comorbidities.

Conclusions

Guideline-driven statin initiation was low, with large inequities by race. With indications for statin use expanding for PWH, redressing barriers to guideline implementation will be crucial to achieving improved outcomes through uptake of these evidence-based therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsHydroxymethylglutaryl-CoA Reductase InhibitorsHumansMaleFemaleProspective StudiesMiddle AgedUnited StatesIncidenceAdultAtherosclerosisAgedRisk Factors

Stichwörter der Autor:innen

HIVcardiovascular diseasecohort studiesstatins

Substanzen

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • UNC Center for AIDS Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • School of Medicine, Emory University, Atlanta, Georgia, USA.
  • Department of Medicine/Infectious Diseases, Georgetown University, Washington, DC, USA.
  • Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.

ORCID-Profile: Tiffany L Breger, Daniel J Westreich, Andrew Edmonds, Jessie K Edwards, Catalina Ramirez, Igho Ofotokun, Deborah Konkle-Parker, Tonya N Taylor, M Bradley Drummond, Michelle A Floris-Moore

Förderung

  • Eunice Kennedy Shriver National Institute of Child Health & Human Development
  • DC CTSA
  • National Institutes of Health, Office of AIDS Research
  • NINR NIH HHS
  • NIAID NIH HHS
  • Atlanta CFAR
  • NIAAA NIH HHS
  • UAB CFAR

Zitieren

APA

Breger, T. L., Westreich, D. J., Edmonds, A., Edwards, J. K., Cole, S. R., Ramirez, C., Diggs, A. E., Ofotokun, I., Kassaye, S. G., Brown, T. T., Konkle-Parker, D., Palella, F. J., Krier, S., Jones, D. L., D'Souza, G., Cohen, M. H., Tien, P. C., Taylor, T. N., Anastos, K., …, & Floris-Moore, M. A. (2025). Incidence of Statin Initiation Among People With and Without HIV in the United States: A Prospective Observational Study. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf207

Vancouver

Breger TL, Westreich DJ, Edmonds A, Edwards JK, Cole SR, Ramirez C, et al. Incidence of Statin Initiation Among People With and Without HIV in the United States: A Prospective Observational Study. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf207

BibTeX
@article{Breger2025,
  author = {Breger, Tiffany L and Westreich, Daniel J and Edmonds, Andrew and Edwards, Jessie K and Cole, Stephen R and Ramirez, Catalina and Diggs, Alicia E and Ofotokun, Igho and Kassaye, Seble G and Brown, Todd T and Konkle-Parker, Deborah and Palella, Frank J and Krier, Sarah and Jones, Deborah L and D'Souza, Gypsyamber and Cohen, Mardge H and Tien, Phyllis C and Taylor, Tonya N and Anastos, Kathryn and Hinderliter, Alan L and Eron, Joseph J and Drummond, M Bradley and Floris-Moore, Michelle A},
  title = {Incidence of Statin Initiation Among People With and Without HIV in the United States: A Prospective Observational Study},
  journal = {Clinical Infectious Diseases},
  year = {2025},
  doi = {10.1093/cid/ciaf207}
}
Kostenlos starten →